Taken together, our findings indicate that a cancer‐driven effect specifically on the primary hemostasis, mainly involving interaction between platelets, adhesive proteins located in the subendothelial matrix (including collagen and von Willebrand factor), and the innate immune system is involved in the formation of LVO clots in patients with cancer. Here, VWF is linked to cancer.